Abstract
Background: Post-repair atrial septal defects (ASD) patients are frequently discharged from follow-up, but the extent of pulmonary symptoms long-term post-repair is unknown. Methods and Results: The national CONgenital CORvitia registry was linked to the national Drug Registry to investigate all ambulatory-dispensed pulmonary inhalants for 2006–2014. ASD patients were compared with age-and sex-matched referents from the general population. A total of 1,959 adult patients (age 42±17 years; 66% female; 1,223 [62%] repaired) were included. Compared with the referents, ASD patients had more inhalant use, even at long-term post-repair follow-up (OR=1.81 [95% CI 1.62–2.03]; P<0.001). Conclusions: ASD patients had 2-fold higher inhalant use compared with referents even at long-term post-repair follow-up, suggesting persistent pulmonary functional impairment.
Original language | English |
---|---|
Pages (from-to) | 2913-2916 |
Number of pages | 4 |
Journal | Circulation journal |
Volume | 82 |
Issue number | 11 |
DOIs | |
Publication status | Published - 25 Oct 2018 |
Keywords
- Administration, Inhalation
- Adult
- Female
- Follow-Up Studies
- Heart Septal Defects/complications
- Humans
- Lung
- Lung Diseases/complications
- Male
- Middle Aged
- Registries